Efficacy and safety of dapagliflozin add-on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study.
In-Kyung JeongKyung Mook ChoiKyung Ah HanKyoung-Ah KimIn Joo KimSeung Jin HanWon Young LeeSoon Jib YooPublished in: Diabetes, obesity & metabolism (2024)
Dapagliflozin add-on to evogliptin plus metformin improved glycaemic control and was well tolerated by the target patients.